Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 4Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 33Lung Neoplasms 18Breast Neoplasms 11Ovarian Neoplasms 10Uterine Cervical Neoplasms 6Carcinoma, Ovarian Epithelial 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Head and Neck Neoplasms 5Fallopian Tube Neoplasms 5Adenocarcinoma of Lung 5Neoplasms 4Neoplasm Metastasis 4Central Nervous System Neoplasms 4Esophageal Neoplasms 3Small Cell Lung Carcinoma 2Sarcoma 2Retinoblastoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Inflammatory Breast Neoplasms 2Gliosarcoma 2Glioblastoma 2Brain Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thoracic Neoplasms 1Salivary Gland Neoplasms 1

Interventions

pertuzumab 1cc-486 1Trastuzumab 1Sulindac 1Magnetic Resonance Spectroscopy 1Epirubicin 1Docetaxel 1Cytarabine 1Carboplatin 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Pathologic Complete Response × Carboplatin × Clear all
NCT05474690 2024-02-26

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Henan Cancer Hospital

Phase 3 Withdrawn
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡